Ulisses Ribaldo Nicolau

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Barbara Burtness, Robert I. Haddad, José Dinis et al. · JAMA Oncology · 2019 · 43 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Oncogenic drivers in 11q13 associated with prognosis and response to therapy in advanced oropharyngeal carcinomas

Mateus Camargo Barros‐Filho, Luciana A. Reis-Rosa, Márcia Hatakeyama et al. · Oral Oncology · 2018 · 36 citations · Full text

Medicine, Cancer Biology, Oncology +11

Impact of human papillomavirus status on survival and recurrence in a geographic region with a low prevalence of HPV‐related cancer: A retrospective cohort study

Rafael De Cicco, Rosilene de Melo Menezes, Ulisses Ribaldo Nicolau et al. · Head & Neck · 2019 · 34 citations

Medicine, Oncology, Cancer Epidemiology +16

Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor‐β receptor I in head and neck cancer

Marcello Ferretti Fanelli, Thiago Bueno de Oliveira, Alexcia Camila Braun et al. · Head & Neck · 2017 · 28 citations

Medicine, Cancer Biology, Oncology +15